Production (Stage)
Artelo Biosciences, Inc.
ARTL
$0.9527
-$0.0023-0.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.47% | -22.94% | 53.78% | -52.16% | -14.53% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.91% | 183.87% | 133.33% | 148.00% | -52.28% |
| Change in Net Operating Assets | 200.17% | 149.40% | -65.58% | 432.43% | -121.62% |
| Cash from Operations | 45.72% | 1.12% | 56.83% | -27.11% | -34.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -81.76% | 331.99% | 338.60% | -42.29% |
| Cash from Investing | -- | -81.76% | 331.99% | 338.60% | -42.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 78.13% | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 78.13% | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | 350.00% | -800.00% | -78.95% | -103.70% | -113.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.73% | -1,247.16% | 212.86% | 73.77% | -5,885.71% |